Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pituitary Neoplasms | 4 | 2021 | 1340 | 0.890 |
Why?
|
| Meningioma | 5 | 2017 | 1209 | 0.810 |
Why?
|
| Meningeal Neoplasms | 5 | 2017 | 1241 | 0.790 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2016 | 127 | 0.620 |
Why?
|
| Hepatectomy | 2 | 2014 | 550 | 0.410 |
Why?
|
| Autophagy | 2 | 2017 | 1301 | 0.360 |
Why?
|
| Liver Regeneration | 1 | 2011 | 210 | 0.360 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1675 | 0.360 |
Why?
|
| Adenoma | 2 | 2017 | 2168 | 0.340 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 689 | 0.330 |
Why?
|
| Hepatocytes | 2 | 2014 | 1209 | 0.330 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 1350 | 0.310 |
Why?
|
| Endothelial Cells | 3 | 2016 | 3455 | 0.270 |
Why?
|
| Gene Expression | 2 | 2016 | 7790 | 0.240 |
Why?
|
| Macrophages | 3 | 2020 | 5655 | 0.230 |
Why?
|
| Fund Raising | 1 | 2023 | 47 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 8425 | 0.220 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3081 | 0.220 |
Why?
|
| Genomics | 1 | 2017 | 5692 | 0.190 |
Why?
|
| DNA Copy Number Variations | 3 | 2017 | 1940 | 0.180 |
Why?
|
| Ischemia | 3 | 2016 | 1911 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 450 | 0.140 |
Why?
|
| Neurofibromin 2 | 1 | 2017 | 267 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2502 | 0.140 |
Why?
|
| Hindlimb | 2 | 2014 | 505 | 0.130 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2014 | 140 | 0.130 |
Why?
|
| Glutathione | 2 | 2016 | 586 | 0.130 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2014 | 4 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11363 | 0.130 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2014 | 18 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2017 | 23387 | 0.130 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 281 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 457 | 0.120 |
Why?
|
| Cysteine | 2 | 2016 | 873 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16665 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 424 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 1866 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2017 | 13029 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3564 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10472 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2012 | 279 | 0.100 |
Why?
|
| Telomerase | 1 | 2016 | 729 | 0.100 |
Why?
|
| Mutation | 6 | 2017 | 29717 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2016 | 8829 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 544 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 317 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 3001 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 21821 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15108 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 638 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 2107 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1525 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9185 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2014 | 2964 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 3502 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2260 | 0.070 |
Why?
|
| Cell Division | 2 | 2011 | 4564 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2633 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9735 | 0.060 |
Why?
|
| Computational Biology | 1 | 2016 | 3518 | 0.060 |
Why?
|
| Cholesterol | 1 | 2012 | 2895 | 0.060 |
Why?
|
| Animals | 9 | 2016 | 168561 | 0.060 |
Why?
|
| Arsenicals | 1 | 2003 | 124 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3639 | 0.050 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2023 | 120 | 0.050 |
Why?
|
| Organizations | 1 | 2023 | 170 | 0.050 |
Why?
|
| Cell Movement | 1 | 2014 | 5212 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4455 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2938 | 0.050 |
Why?
|
| Oxides | 1 | 2003 | 405 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 742088 | 0.050 |
Why?
|
| Calcium | 1 | 2014 | 5753 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2016 | 3456 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9410 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2187 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2003 | 653 | 0.040 |
Why?
|
| Commerce | 1 | 2023 | 591 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9581 | 0.040 |
Why?
|
| Glutaredoxins | 1 | 2016 | 32 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 1504 | 0.040 |
Why?
|
| Chromogranins | 1 | 2017 | 163 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3428 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19223 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 202 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1905 | 0.030 |
Why?
|
| Mice | 4 | 2014 | 81045 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 418 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2012 | 223 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1251 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 60 | 0.030 |
Why?
|
| Foam Cells | 1 | 2012 | 71 | 0.030 |
Why?
|
| Cyclins | 1 | 2014 | 601 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 500 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 2012 | 231 | 0.030 |
Why?
|
| Oncogenes | 1 | 2017 | 1263 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2012 | 475 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 721 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 493 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1811 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 628 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 559 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14554 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2024 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.020 |
Why?
|
| Male | 6 | 2017 | 349538 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2500 | 0.020 |
Why?
|
| Apoptosis | 1 | 2003 | 9715 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2012 | 741 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2128 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3585 | 0.020 |
Why?
|
| Aorta | 1 | 2012 | 2057 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 4197 | 0.010 |
Why?
|
| Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 643 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4282 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4933 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4886 | 0.010 |
Why?
|
| Female | 3 | 2017 | 379592 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 29087 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 57683 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 77098 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 162944 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 213127 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 213712 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_